.svg){kind=small}
Sep-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
In Illinois, Remedi's performance across various categories has shown some interesting dynamics. In the Capsules category, the brand started strong with a rank of 6 in June 2025 but did not maintain its position in the subsequent months, indicating a potential drop in visibility or sales. Meanwhile, in the Concentrates category, Remedi's rank fluctuated slightly, moving from 20 in June to 24 by September 2025, suggesting a slight decline in market position. However, their Tincture & Sublingual products consistently held the third spot from June to September, demonstrating a stable preference among consumers for these products in Illinois. Notably, the sales figures for Tincture & Sublingual products started at a high in June but saw a decrease by September, which could imply a seasonal or competitive influence.
In Massachusetts, Remedi's performance in the Concentrates category showed a positive trend over the summer months. Starting at a rank of 50 in June, Remedi climbed to 22 by August, although it slightly dipped to 25 in September. This upward trajectory, particularly in July and August, suggests that the brand was gaining traction and possibly increasing its market share in the state. The fluctuations in rank could be indicative of competitive pressures or changes in consumer preferences. It's noteworthy that the brand did not appear in the top 30 for other categories in Massachusetts, which might point to a more focused or limited product offering in this market compared to Illinois.
Competitive Landscape
In the competitive landscape of the concentrates category in Illinois, Remedi has experienced fluctuating rankings over the past few months, reflecting a dynamic market environment. In June 2025, Remedi held the 20th position, but despite a brief improvement to 20th in August, it slipped to 24th by September. This indicates a challenging competitive pressure from brands like Avexia, which consistently ranked higher, although it too experienced a decline from 12th in June to 22nd by September. Meanwhile, Legacy Cannabis (IL) maintained a slightly better position than Remedi, although it also saw a downward trend from 16th to 23rd. Interestingly, Mile High Melts made a notable leap from being outside the top 20 in June to securing the 25th position by September, suggesting a potential rising competitor. These shifts underscore the importance for Remedi to strategize effectively to regain and sustain a higher rank amidst such competitive volatility.
Notable Products
In September 2025, Remedi's top-performing product was Indica Relief RSO Syringe (0.5g) within the Concentrates category, maintaining its leading position consistently from June through September with sales of 1760 units. Following closely, Indica Rest RSO Dropper (0.5g) also retained its second-place rank throughout the same period. Indica Rest RSO Syringe (0.5g) climbed to third place by August and maintained this position in September, showing a steady improvement from its fifth-place ranking in June. The CBD/THC 1:5 Rest Tincture (20mg CBD, 100mg THC, 30ml) remained in fourth place since July, after a slight rise from June. Lastly, the CBD/THC 1:1 Relief Tincture (50mg CBD, 50mg THC, 30ml) consistently held the fifth position in both August and September, despite a brief dip to the fifth rank in July from third in June.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
